analysis of statistics

Roadrunner Transportation Systems Inc (NYSE:RRTS)’s share price soared 0.9% or 0.01 to reach at $0.45 during previous trading session. A total of 803663 shares exchanged hands, whereas the company’s average trading volume stands at 1.26 Million shares. Roadrunner Transportation Systems Inc (NYSE:RRTS) has a market capitalization of $509.89 Million and most recently 1.14 Billion outstanding shares have been calculated.

According to sentiments of 1 analysts the mean estimates of short term price target for the company’s stock is marked at $0.6. The most optimistic analyst sees the stock reaching $0.6 while the most conventional predicts the target price at $0.6.

In terms of Buy/Sell recommendations, 1 analysts have a consensus rating of 3 on the shares of Roadrunner Transportation Systems Inc (NYSE:RRTS). Out of rating recommendations 0 have given the stock a Buy while 0 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Roadrunner Transportation Systems Inc (NYSE:RRTS)’s shares slipped -5.11% in the past week and plunged -8.98% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -63.74% while its year to date performance is at -10.1%.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 1.2 along with current ratio for most recent quarter of 1.2. Total debt to equity ratio of Roadrunner Transportation Systems Inc (NYSE:RRTS) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of Allergan Plc (NYSE:AGN) plunged -0.09% or -0.14 to reach at $153.53 during previous trading session. Allergan Plc (NYSE:AGN) has a market capitalization of $51.46 Billion and most recently 335.2 Million outstanding shares have been calculated. A total of 1.79 Million shares exchanged hands, whereas the company’s average trading volume stands at 2.9 Million shares.

According to 17 analysts Allergan Plc (NYSE:AGN)’s price will reach at $184.29 during 52 weeks. Stock’s minimum price target estimates has been figured out at $142 while the maximum price target forecast is established at $255.

According to the recommendations from 17 analysts stock has mean rating of 1.88 on the shares of Allergan Plc (NYSE:AGN). Out of rating recommendations 7 have given the stock a Buy while 6 recommend the stock as Outperform. 9 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Allergan Plc (NYSE:AGN) climbed 2.49% in the past week and soared 9.41% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -17.49% while its year to date performance is at 14.87%.

Total debt to equity ratio of Allergan Plc (NYSE:AGN) for most recent quarter is 0.37 whereas long term debt to equity ratio for most recent quarter is 0.35. The company’s price to free cash flow for trailing twelve months is 11.87. Its quick ratio for most recent quarter is 1 along with current ratio for most recent quarter of 1.1.

Average true range (ATR-14) of the company sets at 3.44, along with its weekly and monthly volatility of 1.94% and 2.53% respectively. Relative strength index (RSI-14) for Allergan Plc (NYSE:AGN) is at 63.21. Beta value of the stock stands at 1.33. Allergan Plc (NYSE:AGN) has a Return on Assets (ROA) of -4.8. The company currently has a Return on Equity (ROE) of -7.4 and a Return on Investment (ROI) of -4.8.